As of October 27, 2026, Endovia Health Sciences, Inc. is a publicly traded company (NYSE: EDVA). The largest holder reporting an active stake on Schedule 13D is Devereux William T, at 29.4%. No bankruptcy or receivership appears in its SEC Form 8-K filings. Founder or officer holdings: Justin Yorke, a director (28.6%); William Meissner, the executive officer (23.8%) (Schedule 13D, October 21, 2025).
About to sign with, pay or invest in Endovia Health Sciences, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Endovia Health Sciences, Inc. a real, registered company?
- Endovia Health Sciences, Inc. files with the SEC under CIK 1553788 (its SEC filings).
- Its shares are listed under the ticker EDVA on NYSE (SEC company record).
- Incorporated in Nevada; business address in Fort Lauderdale, Florida, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under SPLASH BEVERAGE GROUP, INC. in our court records and SEC 8-K records (as of 2026-10-27).
- Leadership changes: the latest reported is Michael Bondurant, Chief Operating Officer (Form 8-K filed 2026-06-12). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names C/M Capital Master Fund, LP (filed 2026-10-22).
Who are Endovia Health Sciences, Inc.'s owners and officers?
Endovia Health Sciences, Inc.: incorporated in Nevada; business address in Fort Lauderdale, Florida; industry Beverages (Schedule 13G, 2026-10-22).
Officers and directors, each with the role and the filing that names them:
- : Director (Form D, 2025-07-08)
- : Director (Form D, 2025-07-08)
- : Director (Form D, 2025-07-08)
- : Director (Form D, 2025-07-08)
- : Executive Officer (Form D, 2025-07-08)
- : Executive Officer (Form D, 2025-07-08)
| Report | Holder | Share |
|---|---|---|
| Schedule 13G, 2026-10-22 | C/M Capital Master Fund, LP | 7.2% |
| Schedule 13G, 2025-11-06 | Aida Aragon | 5.8% |
| Schedule 13D, 2025-10-31 | Fore Thomas Butler | 23.7% |
| Schedule 13G, 2025-10-31 | Tong Magdalene | 7.7% |
| Schedule 13D, 2025-10-27 | Nistico Robert | 7.1% |
| Schedule 13D, 2025-10-21 | Devereux William T | 29.4% |
| Schedule 13D, 2025-10-21 | Yorke Justin W | 28.6% |
| Schedule 13D, 2025-10-21 | Caple Frederick William | 24.1% |
| Schedule 13D, 2025-10-21 | Meissner William R. | 23.8% |
Want the whole picture on Endovia Health Sciences, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Endovia Health Sciences, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Endovia Health Sciences, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
25 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-06-12 | Michael Bondurant | Chief Operating Officer | appointed | |
| Form 8-K, 2026-05-15 | Brady Cobb | Chief Executive Officer | appointed | |
| Form 8-K, 2026-05-15 | William Meissner | President | departed | 2026-06-01 |
Which insiders own Endovia Health Sciences, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , the chairman and chief executive: 38,053 shares (0.59% of shares outstanding) (Form 4, 2025-10-15).
- , a director: 30,000 shares (0.47% of shares outstanding), held indirectly through By Camden Capital LLC (Form 3, 2026-04-30).
- , a director: 1,875 shares (0.03% of shares outstanding), held indirectly through SNS Universal Solutions LLC (Form 4, 2025-10-20).
Shares outstanding: 6,412,521 as of 2026-08-19, from the company's latest SEC cover page.
How much has Endovia Health Sciences, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-07-08 | $33.32M | $36.25M |
| Form D, 2024-09-06 | $600K | $600K |
| Form D, 2024-05-14 | $1.85M | $1.85M |
| Form D, 2023-10-31 | $1.25M | $1.25M |
| Form D, 2023-01-13 | $4M | $4M |
Latest IPO step: Endovia Health Sciences, Inc. amended its IPO registration (S-1/A, 2026-08-20).
IPO filings: S-1/A, 2026-08-20, S-1, 2026-08-07, S-1, 2026-06-12, RW, 2026-01-16, S-1, 2025-12-22; ticker SBEV on NYSE American.
Keep reading
More on Endovia Health Sciences, Inc. and the records around it.
Endovia Health Sciences, Inc. elsewhere on the record
- 5%+ stake filings Oct 2026
- Leadership changes Jun 2026
Companies that share a holder
- C/M Capital Master Fund, LP also filed stake reports on 8 other companies: Catheter Precision, Inc. (Aug 2026), Volato Group, Inc. (Jul 2026), Beeline Holdings, Inc. (Jun 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/endovia-health-sciences